Icell Gene Therapeutics Is A Clinical Stage Biotechnology Company Based In Stony Brooknew Yorkfounded In 2014The Company Focuses On The Research And Development Of Chimeric Antigen Receptorcarengineered Cell Therapies Aimed At Addressing Unmet Medical Needs In Autoimmune Diseases And Cancertheir Innovative Therapies Provide Cost Effective Treatment Options For Conditions With Limited Therapeutic Alternatives The Company Specializes In Proprietary Car Immunotherapiesincluding Car Engineered Cell Therapies For B Cell Mediated Autoimmune Diseases Like Systemic Lupus Erythematosus And Lupus Nephritisthey Also Develop Compound Carsccarsto Enhance The Specificity And Efficacy Of Their Therapiesas Well As Non Gene Editing Car Technology For T Cell Malignanciesadditionallyicell Offers Universal Carsincluding Super Nk Cellsdesigned To Elicit Strong Immune Responses Against Various Cancersicell Gene Therapeutics Is Led By A Team Of Experienced Professionals And Operates Research And Development Teams In Both The United States And Chinafocusing On Advancing Their Innovative Therapies
